VitD/Dexa treatment also reduced the percentage of IFNγ+ CD8+ T cells (Figure 5A, right panel), which have been recently suggested as promoters of atherosclerosis by controlling monopoiesis and circulating monocytes (28). The gene discussed is CD8A; the disease is atherosclerosis.